3,3-DIBUTYL-7-(DIMETHYLAMINO)-2,3,4,5-TETRAHYDRO-5-(4-((4-(HYDROXYMETHYL)PHENYL)METHOXY)PHENYL)-1-BENZOTHIEPIN-4-OL 1,1-DIOXIDE, (4R,5R)-
UNII PT3CVS3J39
Substance Identification & Data
This profile provides standardized clinical and technical data for 3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-5-(4-((4-(hydroxymethyl)phenyl)methoxy)phenyl)-1-benzothiepin-4-ol 1,1-dioxide, (4r,5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PT3CVS3J39.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 361374-22-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H45NO5S UIHYYGVIPWETPT-CZNDPXEESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3,3-dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-5-(4-((4-(hydroxymethyl)phenyl)methoxy)phenyl)-1-benzothiepin-4-ol 1,1-dioxide, (4r,5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.